Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.
Alsup is the COO and chief scientific officer of NDA Group.
Discover more about S&P Global’s offerings
Theravance Biopharma adds independent director
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Theravance Biopharma Inc. appointed Laurie Alsup as an independent director.
Alsup is the COO and chief scientific officer of NDA Group.